AKTS

Aktis Oncology, Inc.

NASDAQHealthcareBiotechnologyUS

USD33.73

+3.62 (+12.02%)

Rating:C+

CEO

Matthew Roden

IPO Date

2026-01-09

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

Open

$29.63

Prev. Close

$30.11

Day Low

$29.49

Day High

$33.84

52W Low

$14.72

52W High

$33.84

Market Cap

$1.80B

Volume

0.20M

Annual Ratios

Date	Period	Gross Margin	Net Margin	ROE	ROA	D/E	Current Ratio	P/E
31 Dec 2025	FY	100.0%	-980.9%	43.6%	-24.1%	-0.08	7.37	-18.5
31 Dec 2024	FY	100.0%	-2957.6%	50.1%	-13.5%	-0.14	15.98

Quarterly Ratios

Date	Period	Gross Margin	Net Margin	ROE	ROA	D/E	Current Ratio	P/E
31 Mar 2026	Q1	79.8%	-567.9%	-3.6%	-3.2%	0.02	19.49	-13.5
31 Dec 2025	Q4	100.0%	-809.5%	10.4%	-5.7%	-0.08	7.37